Reducing Treatment Burden in Inflammatory Dermatoses

In “Reducing Treatment Burden in Inflammatory Dermatoses,” our panel explores the practical challenges associated with managing chronic inflammatory skin diseases using multiple topical corticosteroids. Building on the consensus statement that the use of different corticosteroids for different body areas can create significant burden for patients, the expert faculty discuss how increasingly complex treatment regimens can negatively impact adherence, disease control, and the overall patient experience.

The panel examines the real-world consequences of prescribing multiple corticosteroids with varying potencies, formulations, and application instructions. Faculty members reflect on how even well-designed treatment plans can become overwhelming for patients and caregivers, particularly when different products are prescribed for sensitive areas such as the face and skin folds versus thicker-skinned areas like the hands and feet. The discussion highlights the relationship between treatment complexity and adherence, emphasizing that the more complicated a regimen becomes, the greater the opportunity for confusion, misuse, and inconsistent application.

Throughout the conversation, the panel shares examples from clinical practice illustrating how patients frequently struggle to remember which medication should be used where, leading to inappropriate application, diminished efficacy, and difficulty monitoring overall corticosteroid exposure. The faculty also discuss how polypharmacy can contribute to frustration, reduced confidence in treatment plans, and challenges during follow-up visits. Ultimately, the discussion underscores the importance of simplifying topical treatment strategies whenever possible and considering approaches that support long-term disease management while minimizing patient burden in inflammatory dermatoses.

Our next episode, “Moving Beyond Long-Term Topical Corticosteroid Use in Inflammatory Dermatoses,” features the panelists discussing how long-term safety data for advanced targeted topical therapies is reshaping treatment decisions. The faculty examine the evidence supporting steroid-sparing approaches and explore how newer nonsteroidal topicals are being incorporated into long-term management strategies for inflammatory dermatoses.